相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。In vivo neutralization of the protagonist role of macrophages during the chronic inflammatory stage of Huntington's disease
Jeffrey Pido-Lopez et al.
SCIENTIFIC REPORTS (2018)
Myostatin inhibition prevents skeletal muscle pathophysiology in Huntington's disease mice
Marie K. Bondulich et al.
SCIENTIFIC REPORTS (2017)
An enhanced Q175 knock-in mouse model of Huntington disease with higher mutant huntingtin levels and accelerated disease phenotypes
Amber L. Southwell et al.
HUMAN MOLECULAR GENETICS (2016)
TNF-α Autocrine Feedback Loops in Human Monocytes: The Pro- and Anti-Inflammatory Roles of the TNF-α Receptors Support the Concept of Selective TNFR1 Blockade In Vivo
Jennie M. Gane et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2016)
Enhancement of the immunoregulatory potency of mesenchymal stromal cells by treatment with immunosuppressive drugs
John Girdlestone et al.
CYTOTHERAPY (2015)
Rapid mitochondrial dysfunction mediates TNF-alpha-induced neurotoxicity
Danielle N. Doll et al.
JOURNAL OF NEUROCHEMISTRY (2015)
Characterisation of immune cell function in fragment and full-length Huntington's disease mouse models
Ulrike Trager et al.
NEUROBIOLOGY OF DISEASE (2015)
Amyloid precursor protein metabolism and inflammation markers in preclinical Alzheimer disease
Daniel Alcolea et al.
NEUROLOGY (2015)
Huntington disease
Gillian P. Bates et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
HTT-lowering reverses Huntington's disease immune dysfunction caused by NFκB pathway dysregulation
Ulrike Traeger et al.
BRAIN (2014)
Inhibition of soluble tumor necrosis factor is therapeutic in Huntington's disease
Han-Yun Hsiao et al.
HUMAN MOLECULAR GENETICS (2014)
TNF alpha Promotes Th17 Cell Differentiation through IL-6 and IL-1 beta Produced by Monocytes in Rheumatoid Arthritis
Yingxia Zheng et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2014)
IL-1 and TNF- induce neurotoxicity through glutamate production: a potential role for neuronal glutaminase
Ling Ye et al.
JOURNAL OF NEUROCHEMISTRY (2013)
Correlations of Behavioral Deficits with Brain Pathology Assessed through Longitudinal MRI and Histopathology in the R6/2 Mouse Model of HD
Ivan Rattray et al.
PLOS ONE (2013)
Correlations of Behavioral Deficits with Brain Pathology Assessed through Longitudinal MRI and Histopathology in the R6/1 Mouse Model of Huntington's Disease
Ivan Rattray et al.
PLOS ONE (2013)
NF-κB, the first quarter-century: remarkable progress and outstanding questions
Matthew S. Hayden et al.
GENES & DEVELOPMENT (2012)
Cannabinoid Receptor 2 Signaling in Peripheral Immune Cells Modulates Disease Onset and Severity in Mouse Models of Huntington's Disease
Jill Bouchard et al.
JOURNAL OF NEUROSCIENCE (2012)
Treatment of rheumatoid arthritis with tumour necrosis factor inhibitors
Devesh Mewar et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Targeting TNF-Alpha to Elucidate and Ameliorate Neuroinflammation in Neurodegenerative Diseases
Kathryn A. Frankola et al.
CNS & Neurological Disorders-Drug Targets (2011)
Neuroprotection with a Brain-Penetrating Biologic Tumor Necrosis Factor Inhibitor
Qing-Hui Zhou et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Identical oligomeric and fibrillar structures captured from the brains of R6/2 and knock-in mouse models of Huntington's disease
Kirupa Sathasivam et al.
HUMAN MOLECULAR GENETICS (2010)
TNF-α-induced up-regulation of pro-inflammatory cytokines is reduced by phosphatidylcholine in intestinal epithelial cells
Irina Treede et al.
BMC GASTROENTEROLOGY (2009)
The effect of allogeneic in vitro stimulation and in vivo immunization on memory CD4+ T-cell APOBEC3G expression and HIV-1 infectivity
Pido-Lopez Jeffrey et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Distinct neuroinflammatory profile in post-mortem human Huntington's disease
Aurelio Silvestroni et al.
NEUROREPORT (2009)
A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease
Maria Bjorkqvist et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Optimisation of region-specific reference gene selection and relative gene expression analysis methods for pre-clinical trials of Huntington's disease
Caroline L. Benn et al.
MOLECULAR NEURODEGENERATION (2008)
TNF-α inhibition as a treatment strategy for neurodegenerative disorders:: New drug candidates and targets
David Tweedie et al.
CURRENT ALZHEIMER RESEARCH (2007)
Microglial activation in presymptomatic Huntington's disease gene carriers
Yen F. Tai et al.
BRAIN (2007)
Interleukin-1-induced neurotoxicity is mediated by glia and requires caspase activation and free radical release
Peter Thornton et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Mitochondrial impairment in patients and asymptomatic mutation carriers of Huntington's disease
C Saft et al.
MOVEMENT DISORDERS (2005)
Down-regulation of DENN/MADD, a TNF receptor binding protein, correlates with neuronal cell death in Alzheimer's disease brain and hippocampal neurons
K Del Villar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Infliximab maintenance therapy for fistulizing Crohn's disease
BE Sands et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Interleukin-6 produces neuronal loss in developing cerebellar granule neuron cultures
SM Conroy et al.
JOURNAL OF NEUROIMMUNOLOGY (2004)
Activation of the IκB kinase complex and nuclear factor-κB contributes to mutant Huntingtin neurotoxicity
A Khoshnan et al.
JOURNAL OF NEUROSCIENCE (2004)
Message and protein-level elevation of tumor necrosis factor α(TNFα) and TNFα-modulating cytokines in spinal cords of the G93A-SOD1 mouse model for amyotrophic lateral sclerosis
K Hensley et al.
NEUROBIOLOGY OF DISEASE (2003)
Signalling pathways of the TNF superfamily: A double-edged sword
BB Aggarwal
NATURE REVIEWS IMMUNOLOGY (2003)
Pilot study of recombinant human soluble tumor necrosis factor (TNF) receptor (p75) fusion protein (TNFR:Fc; Enbrel) in patients with refractory multiple myeloma:: increase in plasma TNFα levels during treatment
AM Tsimberidou et al.
LEUKEMIA RESEARCH (2003)
Local neuroinflammation and the progression of Alzheimer's disease
PL McGeer et al.
JOURNAL OF NEUROVIROLOGY (2002)
Environmental enrichment slows disease progression in R61/2 Huntington's disease mice
E Hockly et al.
ANNALS OF NEUROLOGY (2002)
The TNF and TNF receptor superfamilies: Integrating mammalian biology
RM Locksley et al.
CELL (2001)